CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Sale | −900 | $46.94 | $42K | 102,497 |
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Sale | −3,472 | $47.62 | $165K | 99,025 |
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Sale | −6,521 | $48.39 | $316K | 92,504 |
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Sale | −4,107 | $49.35 | $203K | 88,397 |
| 2021-01-25 | Yocca Frank Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −15,000 | 54,310 | ||
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Option exercise | +25,000 | $0.41 | $10K | 25,000 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Sale | −6,758 | $48.43 | $327K | 18,242 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Sale | −12,665 | $49.27 | $624K | 5,577 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Sale | −2,700 | $50.38 | $136K | 2,877 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Sale | −1,500 | $51.45 | $77K | 1,377 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Sale | −1,377 | $52.45 | $72K | 0 |
| 2021-01-19 | O'Neill Vincent Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −25,000 | 74,425 | ||
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Option exercise | +25,000 | $0.41 | $10K | 25,000 |
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Sale | −13,969 | $50.77 | $709K | 11,031 |
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Sale | −5,727 | $51.75 | $296K | 5,304 |
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Sale | −3,951 | $52.68 | $208K | 1,353 |
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Sale | −1,353 | $53.54 | $72K | 0 |
| 2020-12-28 | O'Neill Vincent Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | +25,000 | 99,425 | ||
| 2020-07-24 | BioXcel Holdings, Inc. 10% owner | Other disposition | −160,000 | $60.76 | $9.7M | 9,020,000 |
| 2020-07-24 | BioXcel Holdings, Inc. 10% owner | Other acquisition | +160,000 | $60.76 | $9.7M | 160,000 |
Page 25 of 27 · 521 trades